As of 2025-09-18, the EV/EBITDA ratio of Novocure Ltd (NVCR) is -12.43. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Novocure's latest enterprise value is 1,949.78 mil USD. Novocure's TTM EBITDA according to its financial statements is -156.85 mil USD. Dividing these 2 quantities gives us the above Novocure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 9.2x | 8.2x |
| Forward P/E multiples | 19.0x - 22.8x | 21.2x |
| Fair Price | (31.43) - (17.69) | (25.44) |
| Upside | -347.7% - -239.4% | -300.5% |
| Date | EV/EBITDA |
| 2025-09-16 | -12.42 |
| 2025-09-15 | -12.45 |
| 2025-09-12 | -12.05 |
| 2025-09-11 | -12.46 |
| 2025-09-10 | -12.09 |
| 2025-09-09 | -12.41 |
| 2025-09-08 | -12.37 |
| 2025-09-05 | -12.14 |
| 2025-09-04 | -11.92 |
| 2025-09-03 | -12.00 |
| 2025-09-02 | -12.07 |
| 2025-08-29 | -12.17 |
| 2025-08-28 | -11.96 |
| 2025-08-27 | -11.87 |
| 2025-08-26 | -11.82 |
| 2025-08-25 | -11.73 |
| 2025-08-22 | -12.25 |
| 2025-08-21 | -11.87 |
| 2025-08-20 | -11.78 |
| 2025-08-19 | -11.99 |
| 2025-08-18 | -12.00 |
| 2025-08-15 | -11.75 |
| 2025-08-14 | -11.65 |
| 2025-08-13 | -11.67 |
| 2025-08-12 | -11.47 |
| 2025-08-11 | -11.15 |
| 2025-08-08 | -11.32 |
| 2025-08-07 | -11.59 |
| 2025-08-06 | -11.50 |
| 2025-08-05 | -11.53 |
| 2025-08-04 | -11.77 |
| 2025-08-01 | -11.45 |
| 2025-07-31 | -11.63 |
| 2025-07-30 | -11.20 |
| 2025-07-29 | -11.49 |
| 2025-07-28 | -11.68 |
| 2025-07-25 | -11.97 |
| 2025-07-24 | -12.32 |
| 2025-07-23 | -15.15 |
| 2025-07-22 | -15.00 |
| 2025-07-21 | -14.86 |
| 2025-07-18 | -14.80 |
| 2025-07-17 | -14.94 |
| 2025-07-16 | -15.21 |
| 2025-07-15 | -15.35 |
| 2025-07-14 | -15.80 |
| 2025-07-11 | -15.93 |
| 2025-07-10 | -16.54 |
| 2025-07-09 | -16.35 |
| 2025-07-08 | -15.87 |